May 1961

New Drug Developments 1960: Volume 2 of U.S.D. 1960

Author Affiliations

Arthur Osol, Ph.G., B.S., M.D., Ph.D., Editor-in-Chief, with Robertson Pratt, A.B., Ph.D. Price, $9. Pp. 240. J. B. Lippincott Company, 227-231 S. Sixth St., Philadelphia 5, 1960.

Arch Intern Med. 1961;107(5):796-797. doi:10.1001/archinte.1961.03620050162033

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Because of the never-ending stream, an up-to-date dossier on drugs currently in use is most desirable. Official and semiofficial catalogs, such as the Pharmacopeia of the United States and New and Nonofficial Drugs, will not serve, not only because they do not admit all drugs but also because those which they do admit are usually in use for too long a time before the decision is reached to include them. Thus neither is timely enough nor sufficiently inclusive to serve the purpose. Those compendia which, like The Physician's Desk Reference and Modern Drug Encyclopedia, do not have a selective editorial policy may be up-to-date, but they list drugs according to proprietary names so that the same drug may be described half a dozen times or more under as many different names with no indication that there is duplication. The United States Dispensatory attempts to deal with this problem in its

First Page Preview View Large
First page PDF preview
First page PDF preview